We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Aquestive Therapeutics Inc | NASDAQ:AQST | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.1599 | 4.87% | 3.4399 | 3.44 | 3.45 | 3.54 | 3.26 | 3.30 | 1,213,238 | 18:44:03 |
Delaware
|
001-38599
|
82-3827296
|
(State or Other Jurisdiction
of Incorporation or Organization)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, par value $0.001 per share
|
AQST
|
Nasdaq Global Market
|
Item 5.02 |
Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
Item 9.01 |
Financial Statements and Exhibits
|
Exhibit Number
|
Description
|
|
Separation Agreement, dated May 17, 2022, between Aquestive Therapeutics, Inc. and Keith J. Kendall.
|
||
Press Release issued May 17, 2022
|
Dated: May 17, 2022
|
Aquestive Therapeutics, Inc.
|
|
By:
|
/s/ A. Ernest Toth, Jr.
|
|
Name: A. Ernest Toth, Jr.
|
||
Title: Chief Financial Officer
|
1 Year Aquestive Therapeutics Chart |
1 Month Aquestive Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions